Opko Health [OPK] vs Danaher [DHR] Detailed Stock Comparison
Opko Health
NASDAQ
Loading...
Danaher
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Opko Health wins in 8 metrics, Danaher wins in 10 metrics, with 0 ties. Danaher appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Opko Health | Danaher | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -17.13 | 43.29 | Opko Health |
| Price-to-Book Ratio | 0.82 | 2.79 | Opko Health |
| Debt-to-Equity Ratio | 30.51 | 35.45 | Opko Health |
| PEG Ratio | -4.72 | -1.16 | Opko Health |
| EV/EBITDA | -7.04 | 21.49 | Opko Health |
| Profit Margin (TTM) | -26.68% | 14.21% | Danaher |
| Operating Margin (TTM) | -38.25% | 20.12% | Danaher |
| EBITDA Margin (TTM) | N/A | 20.12% | N/A |
| Return on Equity | -13.16% | 6.68% | Danaher |
| Return on Assets (TTM) | -8.46% | 4.01% | Danaher |
| Free Cash Flow (TTM) | $-208.50M | $5.30B | Danaher |
| 1-Year Return | -12.42% | -21.40% | Opko Health |
| Price-to-Sales Ratio (TTM) | 1.64 | 6.08 | Opko Health |
| Enterprise Value | $1.22B | $161.61B | Danaher |
| EV/Revenue Ratio | 1.83 | 6.73 | Opko Health |
| Gross Profit Margin (TTM) | 31.50% | 59.35% | Danaher |
| Revenue per Share (TTM) | $1 | $33 | Danaher |
| Earnings per Share (Diluted) | $-0.26 | $4.71 | Danaher |
| Beta (Stock Volatility) | 1.19 | 0.76 | Danaher |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Opko Health vs Danaher Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Opko Health | 2.17% | 2.92% | 2.17% | 11.02% | -18.02% | -2.76% |
| Danaher | 3.87% | 0.41% | 11.53% | 12.97% | 0.31% | -7.84% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Opko Health | -12.42% | -38.96% | -57.78% | -87.65% | -35.62% | 271.05% |
| Danaher | -21.40% | -14.78% | 16.18% | 257.83% | 757.84% | 1,089.89% |
Performance & Financial Health Analysis: Opko Health vs Danaher
| Metric | OPK | DHR |
|---|---|---|
| Market Information | ||
| Market Cap | $1.09B | $146.00B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 2,737,240 | 3,163,180 |
| 90 Day Avg. Volume | 2,757,943 | 4,270,123 |
| Last Close | $1.41 | $211.80 |
| 52 Week Range | $1.11 - $2.04 | $171.00 - $279.90 |
| % from 52W High | -30.88% | -24.33% |
| All-Time High | $19.20 (Jun 01, 2015) | $296.06 (Sep 06, 2021) |
| % from All-Time High | -92.66% | -28.46% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.14% | 0.03% |
| Quarterly Earnings Growth | -0.14% | -0.39% |
| Financial Health | ||
| Profit Margin (TTM) | -0.27% | 0.14% |
| Operating Margin (TTM) | -0.38% | 0.20% |
| Return on Equity (TTM) | -0.13% | 0.07% |
| Debt to Equity (MRQ) | 30.51 | 35.45 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $1.66 | $73.10 |
| Cash per Share (MRQ) | $0.34 | $4.13 |
| Operating Cash Flow (TTM) | $-239,462,000 | $6.17B |
| Levered Free Cash Flow (TTM) | $-185,865,120 | $3.88B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Opko Health vs Danaher
| Metric | OPK | DHR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -17.13 | 43.29 |
| Forward P/E | -4.72 | 24.33 |
| PEG Ratio | -4.72 | -1.16 |
| Price to Sales (TTM) | 1.64 | 6.08 |
| Price to Book (MRQ) | 0.82 | 2.79 |
| Market Capitalization | ||
| Market Capitalization | $1.09B | $146.00B |
| Enterprise Value | $1.22B | $161.61B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.83 | 6.73 |
| Enterprise to EBITDA | -7.04 | 21.49 |
| Risk & Other Metrics | ||
| Beta | 1.19 | 0.76 |
| Book Value per Share (MRQ) | $1.66 | $73.10 |
Financial Statements Comparison: Opko Health vs Danaher
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OPK | DHR |
|---|---|---|
| Revenue/Sales | $149.95M | $5.74B |
| Cost of Goods Sold | $107.33M | $2.23B |
| Gross Profit | $42.62M | $3.51B |
| Research & Development | $30.84M | $379.00M |
| Operating Income (EBIT) | $-67.17M | $1.27B |
| EBITDA | $-34.15M | $1.87B |
| Pre-Tax Income | $-73.37M | $1.13B |
| Income Tax | $-5.77M | $175.00M |
| Net Income (Profit) | $-67.61M | $954.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OPK | DHR |
|---|---|---|
| Cash & Equivalents | $436.00M | $1.99B |
| Total Current Assets | $737.60M | $9.53B |
| Total Current Liabilities | $295.86M | $6.65B |
| Long-Term Debt | $368.00M | $15.98B |
| Total Shareholders Equity | $1.31B | $50.86B |
| Retained Earnings | $-2.13B | $44.91B |
| Property, Plant & Equipment | $119.01M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OPK | DHR |
|---|---|---|
| Operating Cash Flow | $-13.76M | $1.47B |
| Capital Expenditures | $67,000 | $-239.00M |
| Free Cash Flow | $-37.75M | $1.05B |
| Debt Repayment | $-9.72M | N/A |
| Common Stock Repurchase | $0 | $-1.08B |
Short Interest & Institutional Ownership Analysis
| Metric | OPK | DHR |
|---|---|---|
| Shares Short | 32.77M | 8.45M |
| Short Ratio | 13.42 | 1.93 |
| Short % of Float | 0.07% | 0.01% |
| Average Daily Volume (10 Day) | 2,737,240 | 3,163,180 |
| Average Daily Volume (90 Day) | 2,757,943 | 4,270,123 |
| Shares Outstanding | 671.55M | 719.10M |
| Float Shares | 376.11M | 637.13M |
| % Held by Insiders | 0.47% | 0.11% |
| % Held by Institutions | 0.26% | 0.83% |
Dividend Analysis & Yield Comparison: Opko Health vs Danaher
| Metric | OPK | DHR |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |